Use of Dobutamine in Patients With Sepsis and Maintained Hypoperfusion After Initial Volemic Resuscitation.

PHASE2Not yet recruitingINTERVENTIONAL

Enrollment

120

Participants

Timeline

Start Date

February 1, 2024

Primary Completion Date

December 31, 2025

Study Completion Date

March 31, 2026

Conditions

SepsisHypoperfusionHyperlactatemia

Interventions

DRUG

Dobutamine

Intravenous infusion of dobutamine in incremental dosis according to perfusion markers for a period of 48 hours after randomization.

Trial Locations (1)

Federal University of São Paulo, São Paulo

All Listed Sponsors

lead

Federal University of São Paulo

OTHER